X-linked sideroblastic anemia with ataxia
diseaseOn this page
Also known as anaemia sideroblastic and spinocerebellar ataxiaanemia, Sex-linked hypochromic Sideroblaanemia, sideroblastic, and spinocerebellar ataxiaanemia, sideroblastic, with ataxia, X-linked recessiveASATPagon Bird Detter syndromePagon-Bird-Detter syndromesideroblastic anaemia with spinocerebellar ataxiasideroblastic anemia with spinocerebellar ataxiaX-linked sideroblastic Anaemia and ataxiaX-linked sideroblastic anaemia and spinocerebellar ataxiaX-linked sideroblastic anaemia with spinocerebellar ataxiaX-linked sideroblastic Anemia and ataxiaX-linked sideroblastic anemia with spinocerebellar ataxiaXLSA-A
Summary
X-linked sideroblastic anemia with ataxia (MONDO:0010524) is a disease caused by ABCB7 (GenCC Definitive), with 1 cohort gene.
At a glance
- Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
- Causal gene: ABCB7 (GenCC Definitive)
- Cohort genes: 1
- ClinVar variants: 29
- Phenotypes (HPO): 32
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Cases/families | 13 | Worldwide | Validated | |
| Point prevalence | <1 / 1 000 000 | Worldwide | Validated |
Signs & symptoms
Clinical features (HPO)
32 HPO clinical features (Orphanet curated; top 32 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0001251 | Ataxia | Very frequent (80-99%) |
| HP:0001903 | Anemia | Very frequent (80-99%) |
| HP:0002066 | Gait ataxia | Very frequent (80-99%) |
| HP:0002167 | Abnormality of speech or vocalization | Very frequent (80-99%) |
| HP:0012187 | Increased erythrocyte protoporphyrin concentration | Very frequent (80-99%) |
| HP:0031936 | Delayed ability to walk | Very frequent (80-99%) |
| HP:0000486 | Strabismus | Frequent (30-79%) |
| HP:0000639 | Nystagmus | Frequent (30-79%) |
| HP:0000750 | Delayed speech and language development | Frequent (30-79%) |
| HP:0001260 | Dysarthria | Frequent (30-79%) |
| HP:0001347 | Hyperreflexia | Frequent (30-79%) |
| HP:0001348 | Brisk reflexes | Frequent (30-79%) |
| HP:0001924 | Sideroblastic anemia | Frequent (30-79%) |
| HP:0002172 | Postural instability | Frequent (30-79%) |
| HP:0002194 | Delayed gross motor development | Frequent (30-79%) |
| HP:0004840 | Hypochromic microcytic anemia | Frequent (30-79%) |
| HP:0011273 | Anisocytosis | Frequent (30-79%) |
| HP:0000717 | Autism | Occasional (5-29%) |
| HP:0001252 | Hypotonia | Occasional (5-29%) |
| HP:0001272 | Cerebellar atrophy | Occasional (5-29%) |
| HP:0001310 | Dysmetria | Occasional (5-29%) |
| HP:0001510 | Growth delay | Occasional (5-29%) |
| HP:0002075 | Dysdiadochokinesis | Occasional (5-29%) |
| HP:0004447 | Poikilocytosis | Occasional (5-29%) |
| HP:0020081 | Pappenheimer bodies | Occasional (5-29%) |
| HP:0034499 | Increased bone marrow iron | Occasional (5-29%) |
| HP:0000028 | Cryptorchidism | Very rare (<1-4%) |
| HP:0000716 | Depression | Very rare (<1-4%) |
| HP:0001250 | Seizure | Very rare (<1-4%) |
| HP:0001992 | Organic aciduria | Very rare (<1-4%) |
| HP:0100543 | Cognitive impairment | Very rare (<1-4%) |
| HP:0100753 | Schizophrenia | Very rare (<1-4%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | X-linked sideroblastic anemia with ataxia |
| Mondo ID | MONDO:0010524 |
| MeSH | C536358 |
| OMIM | 301310 |
| Orphanet | 2802 |
| DOID | DOID:0050554, DOID:0060064 |
| SNOMED CT | 719816006 |
| UMLS | C1845028 |
| MedGen | 335078 |
| GARD | 0000668 |
| Is cancer (heuristic) | no |
Also known as: anaemia sideroblastic and spinocerebellar ataxia · anemia, Sex-linked hypochromic Siderobla · anemia, sideroblastic, and spinocerebellar ataxia · anemia, sideroblastic, with ataxia, X-linked recessive · ASAT · Pagon Bird Detter syndrome · Pagon-Bird-Detter syndrome · sideroblastic anaemia with spinocerebellar ataxia · sideroblastic anemia with spinocerebellar ataxia · X-linked sideroblastic Anaemia and ataxia · X-linked sideroblastic anaemia and spinocerebellar ataxia · X-linked sideroblastic anaemia with spinocerebellar ataxia · X-linked sideroblastic Anemia and ataxia · X-linked sideroblastic anemia with ataxia · X-linked sideroblastic anemia with spinocerebellar ataxia · XLSA-A · Xlsa-A
Data availability: 29 ClinVar variants · 7 GenCC gene-disease records.
Disease family
Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary disease › X-linked disease › X-linked cerebellar ataxia › X-linked sideroblastic anemia with ataxia
Related subtypes (8): ataxia - deafness - intellectual disability syndrome, fragile X-associated tremor/ataxia syndrome, X-linked non progressive cerebellar ataxia, X-linked spinocerebellar ataxia type 3, X-linked spinocerebellar ataxia type 4, X-linked progressive cerebellar ataxia, spinocerebellar ataxia, X-linked 2, X-linked intellectual disability-ataxia-apraxia syndrome
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
29 retrieved; paginated sample, class counts are floors:
11 uncertain significance, 5 benign, 4 pathogenic, 3 benign/likely benign, 3 likely pathogenic, 3 conflicting classifications of pathogenicity
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 11574 | NM_001271696.3(ABCB7):c.1200T>G (p.Ile400Met) | ABCB7 | Pathogenic | criteria provided, single submitter |
| 11575 | NM_001271696.3(ABCB7):c.1297G>A (p.Glu433Lys) | ABCB7 | Pathogenic | no assertion criteria provided |
| 11576 | NM_001271696.3(ABCB7):c.1231G>C (p.Val411Leu) | ABCB7 | Pathogenic | no assertion criteria provided |
| 126455 | NM_001271696.3(ABCB7):c.624A>T (p.Glu208Asp) | ABCB7 | Pathogenic | no assertion criteria provided |
| 3235083 | NM_001271696.3(ABCB7):c.1231G>T (p.Val411Leu) | ABCB7 | Likely pathogenic | criteria provided, single submitter |
| 3248639 | NM_001271696.3(ABCB7):c.2021A>G (p.Asp674Gly) | ABCB7 | Likely pathogenic | criteria provided, single submitter |
| 372878 | NM_001271696.3(ABCB7):c.1235T>C (p.Met412Thr) | ABCB7 | Likely pathogenic | criteria provided, single submitter |
| 368656 | NM_001271696.3(ABCB7):c.1492G>A (p.Gly498Arg) | ABCB7 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications |
| 368659 | NM_001271696.3(ABCB7):c.168+13T>C | ABCB7 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications |
| 914076 | NM_001271696.3(ABCB7):c.1802A>G (p.Gln601Arg) | ABCB7 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications |
| 1333913 | NM_001271696.3(ABCB7):c.2066C>T (p.Thr689Ile) | ABCB7 | Uncertain significance | criteria provided, single submitter |
| 2438737 | NM_001271696.3(ABCB7):c.1106A>G (p.Lys369Arg) | ABCB7 | Uncertain significance | criteria provided, single submitter |
| 2582478 | NM_001271696.3(ABCB7):c.358A>G (p.Ile120Val) | ABCB7 | Uncertain significance | criteria provided, single submitter |
| 368655 | NM_001271696.3(ABCB7):c.1935+5G>C | ABCB7 | Uncertain significance | criteria provided, multiple submitters, no conflicts |
| 4077766 | NM_001271696.3(ABCB7):c.2020G>A (p.Asp674Asn) | ABCB7 | Uncertain significance | criteria provided, single submitter |
| 814010 | NM_001271696.3(ABCB7):c.1936-3C>G | ABCB7 | Uncertain significance | criteria provided, single submitter |
| 914074 | NM_001271696.3(ABCB7):c.*113A>G | ABCB7 | Uncertain significance | criteria provided, single submitter |
| 914075 | NM_001271696.3(ABCB7):c.2073T>C (p.His691=) | ABCB7 | Uncertain significance | criteria provided, single submitter |
| 914587 | NM_001271696.3(ABCB7):c.1230A>G (p.Leu410=) | ABCB7 | Uncertain significance | criteria provided, single submitter |
| 914588 | NM_001271696.3(ABCB7):c.1200T>C (p.Ile400=) | ABCB7 | Uncertain significance | criteria provided, single submitter |
| 976048 | NM_001271696.3(ABCB7):c.944+3A>G | ABCB7 | Uncertain significance | criteria provided, single submitter |
| 1188878 | NM_001271696.3(ABCB7):c.168+69C>G | ABCB7 | Benign | criteria provided, multiple submitters, no conflicts |
| 136242 | NM_001271696.3(ABCB7):c.312C>T (p.Leu104=) | ABCB7 | Benign/Likely benign | criteria provided, multiple submitters, no conflicts |
| 136243 | NM_001271696.3(ABCB7):c.938G>A (p.Arg313Gln) | ABCB7 | Benign/Likely benign | criteria provided, multiple submitters, no conflicts |
| 136244 | NM_001271696.3(ABCB7):c.945-7C>T | ABCB7 | Benign | criteria provided, multiple submitters, no conflicts |
| 136245 | NM_001271696.3(ABCB7):c.1739C>T (p.Ala580Val) | ABCB7 | Benign | criteria provided, multiple submitters, no conflicts |
| 368658 | NM_001271696.3(ABCB7):c.1032+12A>G | ABCB7 | Benign/Likely benign | criteria provided, multiple submitters, no conflicts |
| 559334 | NM_001271696.3(ABCB7):c.201G>C (p.Gln67His) | ABCB7 | Benign | criteria provided, multiple submitters, no conflicts |
| 913727 | NM_001271696.3(ABCB7):c.211A>G (p.Lys71Glu) | ABCB7 | Benign | criteria provided, single submitter |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 7 · Orphanet: 1 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
GenCC gene–disease validity (cohort genes)
the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.
| Gene | Classification | Inheritance | Disease | Records |
|---|---|---|---|---|
| ABCB7 | Definitive | X-linked | X-linked sideroblastic anemia with ataxia | 7 |
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| ABCB7 | Orphanet:2802 | X-linked sideroblastic anemia and spinocerebellar ataxia |
Cohort genes → proteins
1 cohort genes, 1 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 1 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| ABCB7 | HGNC:48 | ENSG00000131269 | O75027 | Iron-sulfur clusters transporter ABCB7, mitochondrial | gencc,clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| ABCB7 | Iron-sulfur clusters transporter ABCB7, mitochondrial | Exports glutathione-coordinated iron-sulfur clusters such as [2Fe-2S]-(GS)4 cluster from the mitochondria to the cytosol in an ATP-dependent manner allowing the assembly of the cytosolic iron-sulfur (Fe/S) cluster-containing proteins and p… |
Protein-family classification
Druggable: 1 · Difficult: 0 · Unknown: 0 · Druggable fraction: 1.0
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Transporter | 1 | 77.8× | 0.013 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| ABCB7 | Transporter | yes | ABC_transporter-like_ATP-bd, AAA+_ATPase, ABC1_TM_dom |
Expression context
Cohort genes with no expression data: 0.
1 cohort gene are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 1 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| biceps brachii | 1 |
| gluteal muscle | 1 |
| triceps brachii | 1 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| ABCB7 | 273 | ubiquitous | marker | biceps brachii, gluteal muscle, triceps brachii |
Protein interactions among cohort
Intra-cohort edges: 0.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| ABCB7 | 1,838 |
Structural data
PDB: 1 · AlphaFold-only: 0 · No structure: 0
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| ABCB7 | O75027 | 4 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 5. Enrichment computed across 1 evidence-associated genes (1 with Reactome annotation).
Pathways by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| Pathway | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| Mitochondrial ABC transporters | 1 | 2855.0× | 0.002 | ABCB7 |
| Cytosolic iron-sulfur cluster assembly | 1 | 761.3× | 0.003 | ABCB7 |
| ABC-family protein mediated transport | 1 | 121.5× | 0.014 | ABCB7 |
| Transport of small molecules | 1 | 25.1× | 0.050 | ABCB7 |
| Metabolism | 1 | 11.6× | 0.086 | ABCB7 |
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| iron-sulfur cluster export from the mitochondrion | 1 | 16852.0× | 2e-04 | ABCB7 |
| positive regulation of iron-sulfur cluster assembly | 1 | 16852.0× | 2e-04 | ABCB7 |
| positive regulation of heme biosynthetic process | 1 | 5617.3× | 5e-04 | ABCB7 |
| iron ion transmembrane transport | 1 | 2407.4× | 8e-04 | ABCB7 |
| negative regulation of reactive oxygen species biosynthetic process | 1 | 991.3× | 0.002 | ABCB7 |
| iron-sulfur cluster assembly | 1 | 601.9× | 0.002 | ABCB7 |
| intracellular iron ion homeostasis | 1 | 244.2× | 0.005 | ABCB7 |
| transmembrane transport | 1 | 168.5× | 0.006 | ABCB7 |
Therapeutics
Drug target analysis
Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 1
Druggability breadth: 1 of 1 evidence-associated genes (100%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| ABCB7 | 0 | 0 |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 0.
Cohort genes with ChEMBL bioactivity (full, sorted by assay count)
| Symbol | Assays | Type breakdown |
|---|---|---|
| ABCB7 | 1 | Binding:1 |
Pharmacogenomics
Cohort genes with a PharmGKB record: 1; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 0 | |
| B | Phased (≥1) drug, not yet approved | 0 | |
| C | Druggable family + PDB, no drug | 1 | ABCB7 |
| D | Druggable family + AlphaFold only, no drug | 0 | |
| E | Difficult family or no structure, no drug | 0 |
Undrugged target profiles
1 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| ABCB7 | 1 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
- Cohort genes: ABCB7